Am Naßtal 4
07751 Jena, de
+49 (3641) 6396-49
New alliance: Imedos Systems GmbH enters into partnership with ALF Distribution GmbH
ALF Distribution GmbH, based in Aachen/Germany, has many years of experience in the identification of high-quality technologies as well as in the direct sale and distribution of devices for non-invasive vascular diagnostics. Expanding its product range to include all of Imedos’ systems for retinal vessel analysis, the company has become the new sales partner. Imedos' Dynamic Vessel Analyzer 3.0 (DVA 3.0) is now a new core product in the portfolio of ALF Distribution. The medical device enables so-called dynamic vessel analysis, an innovative method of retinal vessel analysis, which provides detailed insights into the function and regulation of retinal vessels. For this purpose, the smallest vessels of the retina are first stimulated with flicker light and then analyzed. The vessels of the retina represent the entire human body. They provide important information about general microvascular health. Therefore, they facilitate the assessment of a patient’s personal risk for cardiovascular diseases and events such as strokes and heart attacks, diabetes mellitus, obesity or ocular circulatory disorders (e.g. glaucoma).
"Thanks to this collaboration, we can grow our product range with systems for retinal vessel analysis. As a global distributor of medical devices, we are always on the lookout for new innovative solutions for the everyday clinical life of our customers. The Imedos technologies for the early detection of vascular diseases and the assessment of individual cardiovascular risk are an excellent addition to our offer, especially in the field of cardiovascular research," explains Dipl. Wirtschaftsjurist (FH) Achim Schwarz, Managing Director ALF Distribution GmbH.
Dr. Ing. Walthard Vilser, Managing Director of Imedos Systems GmbH, also welcomes the cooperation: "We look forward to working with ALF Distribution. The company's expertise and strong sales channels open up new market opportunities for us to expand and accelerate our growth in the European market."
Die Nutzung von hier veröffentlichten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Bei Veröffentlichung senden Sie bitte ein Belegexemplar an email@example.com.